334 related articles for article (PubMed ID: 18536613)
21. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.
Tewari A; Dhalla MS; Apte RS
Retina; 2006; 26(9):1093-4. PubMed ID: 17151505
[No Abstract] [Full Text] [Related]
22. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
Sachdev N; Vishwanathan K; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2007; 55(6):457-8. PubMed ID: 17951904
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
[TBL] [Abstract][Full Text] [Related]
24. [Subretinal neovascular membrane in angioid streaks treated with intravitreal bevacizumab].
García-López A; González-Castaño C
Arch Soc Esp Oftalmol; 2014 May; 89(5):203-6. PubMed ID: 24269464
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.
Tetikoglu M; Sagdik HM; Aktas S; Ozcura F
Eye (Lond); 2016 Jun; 30(6):894-5. PubMed ID: 26939555
[No Abstract] [Full Text] [Related]
26. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration.
Chen E; Kaiser RS; Vander JF
Retina; 2007; 27(4):445-50. PubMed ID: 17420696
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
[TBL] [Abstract][Full Text] [Related]
28. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G
Retina; 2006; 26(5):495-511. PubMed ID: 16770255
[TBL] [Abstract][Full Text] [Related]
29. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up.
Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Senel A; Bahcecioglu H
Retina; 2011; 31(7):1279-86. PubMed ID: 21394063
[TBL] [Abstract][Full Text] [Related]
30. Choroidal neovascularization in pathologic myopia.
Dave V; Narayanan R
Am J Ophthalmol; 2010 Nov; 150(5):752; author reply 752-3. PubMed ID: 21036211
[No Abstract] [Full Text] [Related]
31. [Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: a report of 2 cases].
González-Gómez A; Morillo MJ; González-Escobar AB; García-Campos JM
Arch Soc Esp Oftalmol; 2012 May; 87(5):153-6. PubMed ID: 22554559
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-up.
Zebardast N; Adelman RA
Semin Ophthalmol; 2012; 27(3-4):61-4. PubMed ID: 22784267
[TBL] [Abstract][Full Text] [Related]
33. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
34. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
35. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.
Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2006 Oct; 84(5):707-8. PubMed ID: 16965507
[No Abstract] [Full Text] [Related]
36. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.
Heier JS; Brown D; Ciulla T; Abraham P; Bankert JM; Chong S; Daniel PE; Kim IK
Ophthalmology; 2011 Jan; 118(1):111-8. PubMed ID: 20678799
[TBL] [Abstract][Full Text] [Related]
37. Detection of nonexudative choroidal neovascularization secondary to angioid streaks using optical coherence tomography angiography.
Andreanos KD; Rotsos T; Koutsandrea C; Kymionis GD; Georgalas I; Ladas ID
Eur J Ophthalmol; 2017 Aug; 27(5):e140-e143. PubMed ID: 28574138
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks.
Apte RS
Eye (Lond); 2008 May; 22(5):734-5. PubMed ID: 18344971
[No Abstract] [Full Text] [Related]
39. Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks.
Lazaros K; Leonidas Z
Acta Ophthalmol; 2010 May; 88(3):e100-1. PubMed ID: 19900208
[No Abstract] [Full Text] [Related]
40. Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.
Carneiro AM; Silva RM; Veludo MJ; Barbosa A; Ruiz-Moreno JM; Falcão MS; Brandão EM; Falcão-Reis FM
Ophthalmologica; 2011; 225(2):81-8. PubMed ID: 20881442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
